Unicycive Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Aggarwal Gaurav | — | C | 652,900 | — | — | 1,789,915 | Aug 25, 2025 |
| Aggarwal Gaurav | — | C | 1,400,000 | — | — | 11,370,152 | Feb 18, 2025 |
| Aggarwal Gaurav | — | C | 5,500,000 | — | — | 9,970,152 | Oct 9, 2024 |
| Aggarwal Gaurav | — | C | 3,470,152 | — | — | 3,470,152 | Jul 11, 2023 |
| Jermasek Douglas | EVP of Corporate Strategy | Option Exercise | 104,612 | — | — | 175,012 | Jul 11, 2023 |
| Gupta Pramod | EVP, Pharmaceuticals and BD | Option Exercise | 41,845 | — | — | 41,845 | Jul 11, 2023 |
| Gupta Shalabh K. | CEO | Option Exercise | 104,612 | — | — | 2,527,449 | Jul 11, 2023 |
| Schiller Brigitte | — | Option Exercise | 26,738 | — | — | 26,738 | Jul 15, 2022 |
| Schiller Brigitte | — | Purchase | 15,000 | $0.83 | $12,450 | 15,000 | May 16, 2022 |